ENDP

Endo International PLC

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

ENDP price

Endo International

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ENDP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals ENDP

Valuation

P/E

Sector -3.50

Industry -3.50

P/BV

Sector 2.01

Industry 2.01

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

Sector -223.67

Industry -223.67

EV/EBIT

Sector -47.92

Industry -47.92

P/EBITDA

Sector -21.50

Industry -21.50

P/EBIT

Sector -28.21

Industry -28.21

P/Total Assets

Sector 1.19

Industry 1.19

P/Net Current Assets

Sector -10.26

Industry -10.26

P/Working Capital

Sector -167.98

Industry -167.98

EPS

Sector -1.79

Industry -1.79

BVPS

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

Sector 41.30%

Industry 41.30%

EBITDA Margin

-116.83%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-134.93%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

Sector -35.21%

Industry -35.21%

Net Profit Margins

Sector -35.91%

Industry -35.91%

Asset Turnover

0.09

Sector 0.02

Industry 0.02

Profitability

ROE

Sector -56.67%

Industry -56.67%

ROA

Sector -59.91%

Industry -59.91%

ROIC

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

Sector -8.06

Industry -8.06

Net Debt / Equity

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

Sector -0.85

Industry -0.85

Equity/Assets

-0.65

Sector 0.46

Industry 0.46

Liabilities/Assets

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

-3.14%

Sector -

Industry -

5Y Earnings CAGR

39.52%

Sector -

Industry -

Fundamentals ENDP

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ENDP Endo International PLC	$0.00	-	0.00%	0.00	0.00	0.00%	0.00%
JNJ Johnson & Johnson	$269.99	56.71%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.66	23.21%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.96	22.44%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.24	-26.07%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.87	87.26%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.08	10.74%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$63.06	48.20%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$71.40	-50.11%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$385.65	38.85%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.85	33.10%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$112.45	44.52%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.65	25.89%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$508.34	32.68%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$225.38	52.58%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$990.32	34.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.02	29.13%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ENDP Historical Dividends

current DY: %

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Endo International

Endo International PLC

Average Investor10 user rating

4.0 (0 people)

United States

13 years

Founded: 2013

2000

Time since IPO - 26 years

3.397

Employees

Endo International PLC (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $-3.93 billion.

The company employs approximately 3.397 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Endo International PLC reported $2.55 billion in revenue, generating net income of $-3.24 billion.

Key financial metrics include a P/E ratio of -, a price-to-book (P/B) ratio of -, and a trailing twelve-month dividend yield of -.

The company trades under the ticker ENDP.

Market cap

Net worth

$-3.93 billion

$-3,925,041,000.00

Assets

$6.01 billion

$6,006,457,000.00

Total Shares Outstanding

235.20 million

235,199,000

Average Daily Trading Volume

$15.65 million

$15,645,835.00

Sector

Health Care

Industry

Biotechnology

ENDP

ENDP revenue and profits

Financial Results ENDP

DRAG THE FRAME TO SEE MORE DATA

ENDP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.65 25,89% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$225.38 52,58% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.99 56,71% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.96 22,44% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.87 87,26% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.08 9,00% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.66 23,21% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.65 25,89% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$225.38 52,58% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.99 56,71% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.96 22,44% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.87 87,26% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.08 9,00% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.66 23,21% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Endo International (ENDP) today?

A cotação de Endo International (ENDP) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Endo International (ENDP) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Endo International (ENDP) e dados de ações do Ibovespa e mercados internacionais.

Quando Endo International (ENDP) paga dividendos?

Endo International (ENDP) não distribuiu dividendos no último ano.

Is Endo International (ENDP) a good investment?

Atualmente, Endo International (ENDP) está cotada a US$ 0.00, com um P/L de 0.00, representando um desvio de 0% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de -%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Endo International (ENDP) stock?

Investir em ações de Endo International (ENDP) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Endo International (ENDP) yield today?

A rentabilidade de Endo International (ENDP) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de -%.

Se você quisesse comprar 100 ações de Endo International (ENDP) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ENDP

Endo International PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ENDP

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ENDP WITH OTHER STOCK

current DY: %

5-year average DY: 0.00%

ABOUT Endo International

Endo International PLC

United States

13 years

2000

3.397

PROFIT X PRICE ENDP

Financial Results ENDP

ENDP cash flow

Asset, Revenue and Profit Growth - ENDP

ENDP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions